Pharmacologic evidence for the involvement of central and peripheral opioid receptors in the cardioprotective effects of fentanyl

Anesthesia and Analgesia

Volumn 103, Issue 4, 2006, Pages 815-821

  Lessa, Marcos A ^a   Tibiriçá, Eduardo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALOXONE; FENTANYL; GLUTAMIC ACID; NALOXONE; OPIATE; OPIATE RECEPTOR;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; INCIDENCE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SYMPATHETIC TONE; TREATMENT OUTCOME;

ANIMALS; ARRHYTHMIA; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NALOXONE; NARCOTIC ANTAGONISTS; RABBITS; RECEPTORS, OPIOID;

EID: 33750038296     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000237284.30817.f6     Document Type: Article

References (26)

1. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001;89:123-37.
2. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78:1100-4.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
4. Groban L, Vernon JC, Butterworth J. Intrathecal morphine reduces infarct size in a rat model of ischemia-reperfusion injury. Anesth Analg 2004;98:903-9.
5. Latson TW, McCarroll SM, Mirhej MA, et al. Effects of three anesthetic induction techniques on heart rate variability. J Clin Anesth 1992;4:265-76.
6. Komatsu T, Kimura T, Sanchala V, et al. Effects of fentanyl-diazepam- pancuronium anesthesia on heart rate variability: a spectral analysis. J Cardiothorac Vasc Anesth 1992;6:444-8.
7. Saini V, Carr DB, Hagestad EL, et al. Antifibrillatory action of the narcotic agonist fentanyl. Am Heart J 1988;115:598-605.
8. Flacke JW, Flacke WE, Bloor BC, Olewine S. Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs. Anesth Analg 1983;62:305-13.
9. Flacke JW, Davis LJ, Flacke WE, et al. Effects of fentanyl and diazepam in dogs deprived of autonomic tone. Anesth Analg 1985;64:1053-9.
10. Laubie M, Schmitt H. Origin of the hypotensive and sympathoinhibitory effect of morphinomimetic agents. Eur J Pharmacol 1983;91:431-9.
11. Lessa MA, Rodrigues E, Tibirica E. Cardioprotective action of fentanyl in a model of central sympathetic overactivity in rabbits: anti-arrhythmic and anti-ischemic effects. Acta Anaesthesiol Scand 2004;48:1115-22.
12. Sawyer CH, Everett JW, Green JD. The rabbit diencephalon in stereotaxic coordinates. J Comp Neurol 1954;101:801-24.
13. Chien GL, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol 1996;28:1895-900.
14. Okubo S, Tanabe Y, Takeda K, et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of δ-opioid receptor. Am J Physiol Heart Circ Physiol 2004;287:H1786-H1791.
15. Giles T, Sander G, Merz H. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses. Eur J Pharmacol 1983;95:247-52.
16. Gautret B, Schmitt H. Multiple sites for the cardiovascular actions of fentanyl in rats. J Cardiovasc Pharmacol 1985;7:649-52.
17. Daskalopoulos NT, Laubie M, Schmitt H. Localization of the central sympatho-inhibitory effect of a narcotic analgesic agent, fentanyl, in cats. Eur J Pharmacol 1975;33:91-7.
18. Lishmanov YB, Maslov LN. Opioid receptors and heart resistance to arrhythmogenic factors. Bull Exp Biol Med 2004;138:107-12.
19. Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 2002;93:51-75.
20. Gage JC, Eisenach JC. New intra-axial agents and their safety issues. Anesthesiol Clin North Am 1997;1:65-102.
21. Schomig A, Richardt G, Kurz T. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. Herz 1995;20:169-86.
22. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 2005;101:1275-87.
23. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 2002;49:777-91.
24. Kato R, Foex P. Fentanyl reduces infarction but not stunning via δ-opioid receptors and protein kinase C in rats. Br J Anaesth 2000;84:608-14.
25. Villemagne PS, Dannals RF, Ravert HT, Frost JJ. PET imaging of human cardiac opioid receptors. Eur J Nucl Med Mol Imaging 2002;29:1385-8.
26. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46.